Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 486 across all filing types
Latest filing 2024-08-28 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
2024年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2024 年半年度报告' which translates to '2024 Semi-Annual Report'. It contains detailed financial data, management discussion and analysis, company overview, accounting data, and financial indicators for the period January to June 2024. The document is comprehensive, with 198 pages and 15,000 characters, indicating it is a full report rather than a brief announcement. It includes sections such as management discussion and analysis, financial statements, and risk factors, which are typical of an Interim / Quarterly Report. The document explicitly states it is a half-year report and includes unaudited financial data for the first half of 2024. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-28 Chinese
海通证券股份有限公司关于和元生物技术（上海）股份有限公司董事、高级管理人员暨核心技术人员离职的核查意见
Board/Management Information Classification · 95% confidence The document is a detailed verification opinion from Haitong Securities regarding the resignation of a director, senior management, and core technical personnel at Heyuan Biotechnology (Shanghai) Co., Ltd. It includes specifics about the individual's roles, shareholdings, intellectual property, confidentiality agreements, and the impact of the resignation on the company. The document is not a financial report, earnings release, or regulatory filing about financial results. It is a formal announcement related to changes in senior management and board members. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3124 characters, which is consistent with a detailed management change announcement rather than a full report or a brief notice.
2024-08-28 Chinese
股东减持股份时间过半未减持股份暨减持进展公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding the progress of a shareholder's planned reduction in shareholding. It details the shareholders involved, their shareholding percentages, the planned reduction amount, and the status of the reduction plan implementation. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory disclosure about shareholding changes and reduction progress, not a financial report or earnings release. It fits the category of Major Shareholding Notification (MRQ) as it concerns changes in significant share ownership levels and their progress.
2024-07-23 Chinese
2023年年度报告（更新版）
Annual Report Classification · 100% confidence The document is titled '2023 年年度报告' which translates to '2023 Annual Report'. It is issued by 和元生物技术（上海）股份有限公司 (Obio Technology (Shanghai) Corp., Ltd.). The content includes detailed financial data, management discussion and analysis, company overview, risk factors, governance, and audited financial statements. It also mentions the audit report by 天健会计师事务所 with an unqualified opinion, and the report covers the full fiscal year 2023 (January to December). The document length is substantial (15,000 characters and more), indicating it is the full report rather than an announcement. The presence of comprehensive financial data, management analysis, and audit information confirms this is the official Annual Report. Therefore, the correct classification is '10-K' (Annual Report). FY 2023
2024-06-24 Chinese
2023年年度报告的信息披露监管问询函的回复公告
Annual Report Classification · 95% confidence The document is a detailed reply announcement from a company regarding a regulatory inquiry about its 2023 Annual Report. It references the 2023 Annual Report multiple times, discusses detailed financial and operational data for the year 2023, and addresses specific questions raised by the Shanghai Stock Exchange about the annual report. The document includes extensive financial and business performance information, customer data, order status, and risk analysis related to the annual report period. It is not a brief announcement of report publication but a substantive response containing detailed data and analysis. Therefore, this document is best classified as an Annual Report (10-K) type filing, as it contains comprehensive information about the company's yearly performance and regulatory responses related to the annual report. FY 2023
2024-06-24 Chinese
问询函专项说明
Annual Report Classification · 95% confidence The document is a detailed response to an inquiry letter regarding the 2023 annual report of a company, specifically addressing financial performance, business operations, and audit procedures. It contains extensive financial data, analysis of revenue, costs, profit changes, and audit verification steps. The presence of detailed financial tables, explanations of profit and loss, cost structures, and audit opinions indicates this is a comprehensive financial report covering a full fiscal year. The document is not a brief announcement or a presentation but a substantive report with financial statements and management explanations. Therefore, it fits the definition of an Annual Report (10-K). FY 2023
2024-06-24 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.